|
Designated Public Office Holders who participated in the communication:
|
Jeremy Patzer,
Member of Parliament
House of Commons
|
| |
List of Details
|
Subject matter
|
Detail
|
|
Health
|
Canadian Agency for Drugs and Technologies in Health (CADTH), including Therapeutic Reviews and the Common Drug Review as it relates to reimbursement recommendations for decision-making process and framework.
|
|
Health,
Industry
|
Science and Technology Strategy, advocating for the development of a Biopharma sector in support of more research & development in Canada.
|
|
| |
|
Responsible Officer who filed this communication report:
|
Mark Vineis
|
| |
|
As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication. The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed.
|
| |
